Emerging risks associated with weight loss drugs
The rise of GLP-1 drugs represents a significant medical advance but the potential to significantly reduce obesity-related health problems also comes with substantial risks
Insurers and legal professionals must work hand in hand with healthcare providers and regulators to build a consensus around safe usage, fair liability allocation and effective risk mitigation